Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 47 Issue 8, August 2015

San rock art in the Western Cape, South Africa

Editorial

  • From the Human Genome Organization (HUGO) onward, there has been a desire to get together to talk about using our shared genomic heritage to improve human health and development. We now have all the organizations we need and should collaborate on multiple practical demonstrations of the usefulness of genomic knowledge—be it human, animal or plant—for human health.

    Editorial

    Advertisement

Top of page ⤴

Obituary

Top of page ⤴

News & Views

  • Relapsed neuroblastoma is common, frequently lethal and poorly studied and poses a major treatment challenge. Two new studies shed light on the genomic landscape of recurrent neuroblastoma and demonstrate profound differences between the disease at diagnosis and relapse.

    • Vijay Ramaswamy
    • Michael D Taylor
    News & Views
  • Copy number variation (CNV) at several genomic loci has been associated with different human traits and diseases, but in many cases the findings could not be replicated. A new study provides insights into the degree of variation present at the amylase locus and calls into question a previous association between amylase copy number and body mass index.

    • Stefan White
    News & Views
  • A major challenge in human genetics is pinpointing which non-coding genetic variants affect gene expression and disease risk. A new study in this issue describes a broadly applicable approach for this task that explicitly models cell type–specific regulatory motifs and generates variant effect predictions that are more accurate and interpretable than those of alternative tools.

    • Martin Kircher
    • Jay Shendure
    News & Views
Top of page ⤴

Analysis

  • Matthew Nelson and colleagues investigate how well genetic evidence for disease susceptibility predicts drug mechanisms. They find a correlation between gene products that are successful drug targets and genetic loci associated with the disease treated by the drug and predict that selecting genetically supported targets could increase the success rate of drugs in clinical development.

    • Matthew R Nelson
    • Hannah Tipney
    • Philippe Sanseau
    Analysis
Top of page ⤴

Brief Communication

  • Hajime Okita and colleagues show that clear-cell sarcoma of the kidney (CCSK) is characterized by recurrent in-frame, internal tandem duplications in BCOR. They detected BCOR alterations in all 20 CCSK tumors analyzed but not in any other pediatric renal tumors, suggesting a specific role for these in-frame duplications in driving CCSK oncogenesis.

    • Hitomi Ueno-Yokohata
    • Hajime Okita
    • Nobutaka Kiyokawa
    Brief Communication
Top of page ⤴

Article

  • John Maris, Jan Molenaar, Gudrun Schleiermacher and colleagues performed whole-genome sequencing of 23 paired diagnostic and relapsed neuroblastomas, showing enrichment for mutations in the RAS-MAPK signaling pathway. These mutations render neuroblastoma cell lines susceptible to MEK inhibition.

    • Thomas F Eleveld
    • Derek A Oldridge
    • John M Maris
    Article
  • Alexander Schramm, Johannes Schulte and colleagues characterize 16 paired samples from patients with neuroblastoma at diagnosis and relapse using whole-exome sequencing, mRNA expression profiling, array CGH and DNA methylation analysis. Their data show the frequency, identity and evolution of genetic alterations in neuroblastoma.

    • Alexander Schramm
    • Johannes Köster
    • Johannes H Schulte
    Article
  • Richard Gilbertson and colleagues report an in vivo screen of 84 candidate oncogenes and 39 candidate tumor-suppressor genes in ependymoma mouse models. The validated targets are involved in vesicle trafficking, DNA modification and cholesterol biosynthesis.

    • Kumarasamypet M Mohankumar
    • David S Currle
    • Richard J Gilbertson
    Article
  • Simon Gayther and colleagues report 3 new risk variants for mucinous ovarian carcinoma (MOC) on the basis of an analysis of 1,644 MOC cases and 21,693 controls. They confirm an eQTL association between the HOXD9 promoter and risk SNPs at 2q31.1 using chromosome conformation capture analysis and show that HOXD9 overexpression associates with neoplastic transformation.

    • Linda E Kelemen
    • Kate Lawrenson
    • Andrew Berchuck
    Article
  • Soumya Raychaudhuri and colleagues present a detailed analysis of the association between the HLA region and type 1 diabetes risk. They find that variants at three amino acid positions in HLA-DQβ1 and HLA-DRβ1 account for a large fraction of the association signal, acting through a combination of additive and interaction effects.

    • Xinli Hu
    • Aaron J Deutsch
    • Soumya Raychaudhuri
    Article
Top of page ⤴

Letter

Top of page ⤴

Technical Report

  • Michael Beer and colleagues report a metric based on a regulatory region annotation method, gkm-SVM, and use this to predict the effects of regulatory variants from sequencing and DNase I–hypersensitive site data. They apply their method to autoimmune disease GWAS data and report several new predictions for causal SNPs.

    • Dongwon Lee
    • David U Gorkin
    • Michael A Beer
    Technical Report
Top of page ⤴

Erratum

Top of page ⤴

Corrigendum

Top of page ⤴

Search

Quick links